Niraparib for the treatment of metastatic ccRCC in a patient with CDK12 and RAD51C mutations: a case report

BackgroundNiraparib, a poly ADP-ribose polymerase inhibitors (PARPi), has been widely applied in the intervention of epithelial ovarian, fallopian tube, or primary peritoneal cancer. Nevertheless, as of the present moment, there are limited instances demonstrating favorable outcomes stemming from ni...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaolong Yue (Author), Chenkang Yang (Author), Dandan Cao (Author), Yue Li (Author)
Format: Book
Published: Frontiers Media S.A., 2024-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available